Chris Degnan - Chief Financial Officer at UroGen Pharma Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
URGN on Nasdaq
All Insider Reports
All Insider Reports

Chris Degnan - trading volume in the past year for UroGen Pharma Ltd.

Holdings reported by Chris Degnan for UroGen Pharma Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 2,280 $38,418 $16.85 08 Oct 2025 Direct
Restricted Stock Units 32,609 31 Jan 2026 Direct Ordinary Shares

Transactions reported by Chris Degnan for UroGen Pharma Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.